果糖注射液临床使用合理性分析  

Analysis of the Rationality of Fructose Injection in Clinical Use

作　　者：王海平[1] 胡卡芬[2] 陈雪华[1] 简小燕[1] 

机构地区：[1]龙岩市第二医院药剂科,福建龙岩364000 [2]福建医科大学附属漳州市医院药剂科,漳州363000

出　　处：《中国执业药师》2015年第11期51-54,共4页China Licensed Pharmacist

摘　　要：目的:了解果糖注射液在我院临床使用情况及合理性。方法:随机抽取我院2014年第4季度6 164份应用果糖注射液的123份病历,分别从科室应用比例、适应证、疗程及日用量、配伍情况等方面进行统计分析。结果:外科使用比例最高(98,79.67%),其次为内科(25,20.33%);疗程多在10 d以内(98,79.67%),超过10 d的共25例(20.33%);日均用量多在500 mL以内(104,84.55%),日用药量500 m L以上的共19例(15.45%);超适应证使用(13,10.57%)现象时有发生;与果糖注射液配伍的41种药品中,12种存在配伍依据。结论:果糖注射液在我院临床使用存在一定问题,应进一步加强管理,提高用药安全性。Objective： To explore the clinical use of fructose injection in our hospital so as to analyze the rationality of use. Methods： About 123 medical records including the application of fructose injection were randomly collected from 6 164 cases in our hospital in the 4th quarter of 2014. The analysis was conducted statistically in the respects of the proportion of department consumption, indications, treatment course, daily dosage and the compatibility of antibiotics, etc. Results： The Highest proportion of use was showed in surgical department （98, 79.67%） and then in internal department （25, 20.33%）. The treatment course was mostly within 10 days （98, 79.67%） and 25 cases used the drug over 10 days （20.33%）. The average daily dosage mostly was within 500 rnL（104, 84.55%） and 19 cases over 500 mL（15.45%）. Super indications occurred at times （13,10.57%）. Out of 41 kinds of drugs compatible with fructose injection 12 drugs had the compatibility evidence. Conclusion： Certain problems existed in the use of fructose injection in our hospital. The management should be strengthened so as to improve medication safety.

关 键 词：果糖注射液 合理用药 配伍 

分 类 号：R977.6[医药卫生—药品]